Bain Capital Specialty Finance, Inc. current report, 25 May 2023

SEC Filing Summary: Bain Capital Specialty Finance, Inc. (BCSF)

Business Context and Reporting Period

This Form 8-K Current Report, dated May 25, 2023, details the results of the 2023 Annual Meeting of Stockholders held by Bain Capital Specialty Finance, Inc. The report covers voting outcomes for director elections and a specific authorization regarding share sales. As of the record date of April 10, 2023, there were 64,562,265 shares of common stock entitled to vote.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance and voting results.

Material Changes and Voting Results

Stockholders voted on two primary proposals at the Annual Meeting:

  • Proposal I (Director Elections): Stockholders elected three Class I Directors to serve until the 2026 annual meeting. All nominees received a majority of votes cast.
    • Amy Butte: 22,460,214 votes For; 9,923,436 votes Against; 575,754 Abstain.
    • Thomas A. Hough: 22,504,603 votes For; 9,907,057 votes Against; 547,744 Abstain.
    • Clare S. Richer: 22,486,093 votes For; 9,898,175 votes Against; 575,136 Abstain.
  • Proposal II (Below NAV Sales Authorization): Stockholders renewed the authorization for the Company to sell shares of common stock at a price below the then-current net asset value per share, subject to Board approval and certain limitations.
    • Votes For: 30,447,392
    • Votes Against: 1,881,884
    • Abstain: 630,128

Guidance, Outlook, and Risks

The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the final voting tallies.

Key Facts for Investor Verification

  • Verify the tenure of the newly elected Class I Directors (Amy Butte, Thomas A. Hough, Clare S. Richer) extending to the 2026 annual meeting.
  • Confirm the specific limitations and Board approval requirements associated with the renewed authorization to sell shares below net asset value.
  • Note the significant number of votes cast against the director nominees (approximately 9.9 million each), which may warrant review of shareholder sentiment.
  • Review the proxy statement filed on April 21, 2023, for detailed context on the proposals and the "below NAV" sale limitations.